Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Aug 2022 for La Jolla Pharmaceutical Co, €64k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Michael S. Hearne: trading record in brief
Michael S. Hearne (finance chief) discloses dealings in 2 companies, chiefly Odonate Therapeutics, Inc. and La Jolla Pharmaceutical Co. Between 30 November 2018 and 22 August 2022, the trades on record add up to 93 filings.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 24 August 2022: a transaction of €64k, in La Jolla Pharmaceutical Co. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Michael S. Hearne
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations92 total
10,186 shares@ US$6.2375.0% of flowCommon StockSEC:0000899243-22-029649:0
236 shares@ US$2.71150.7% of flowCommon StockSEC:0001209191-22-040873:0
236 shares@ US$2.720.7% of flowCommon StockSEC:0001209191-22-037956:0
189 shares@ US$3.40850.7% of flowCommon StockSEC:0001209191-22-033597:0
188 shares@ US$3.40850.7% of flowCommon StockSEC:0001209191-22-029751:0
185 shares@ US$3.4680.7% of flowCommon StockSEC:0001209191-22-026783:0
173 shares@ US$3.71450.7% of flowCommon StockSEC:0001209191-22-024634:0
177 shares@ US$3.62950.7% of flowCommon StockSEC:0001209191-22-022587:0
190 shares@ US$3.3660.7% of flowCommon StockSEC:0001209191-22-019899:0
185 shares@ US$3.47650.7% of flowCommon StockSEC:0001209191-22-014875:0
169 shares@ US$3.7910.7% of flowCommon StockSEC:0001209191-22-010852:0
1,675 shares@ US$3.93556.9% of flowCommon StockSEC:0001209191-22-006559:0
148 shares@ US$4.1820.6% of flowCommon StockSEC:0001209191-22-003889:0
157 shares@ US$3.91850.6% of flowCommon StockSEC:0001209191-22-000956:0
173 shares@ US$3.57850.6% of flowCommon StockSEC:0001209191-21-070378:0
186 shares@ US$3.3150.6% of flowCommon StockSEC:0001209191-21-067643:0
181 shares@ US$3.40850.6% of flowCommon StockSEC:0001209191-21-065155:0
181 shares@ US$3.4170.6% of flowCommon StockSEC:0001209191-21-062451:0
183 shares@ US$3.3660.6% of flowCommon StockSEC:0001209191-21-060947:0
182 shares@ US$3.39150.6% of flowCommon StockSEC:0001209191-21-059054:0
546 shares@ US$3.39151.8% of flowCommon StockSEC:0001209191-21-056669:0
201 shares@ US$3.06850.6% of flowCommon StockSEC:0001209191-21-049386:0
193 shares@ US$3.1960.6% of flowCommon StockSEC:0001209191-21-047252:0
170 shares@ US$3.6380.6% of flowCommon StockSEC:0001209191-21-045200:0
148 shares@ US$4.1650.6% of flowCommon StockSEC:0001209191-21-041585:0
25 of 92 declarations
